𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Prophylactic Administration of Recombinant Erythropoietin in the Management of Ovarian Cancer: Time for a Definitive Phase 3 Randomized Trial

✍ Scribed by Maurie Markman

Book ID
112251948
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
19 KB
Volume
86
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of gabapentin in the management
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)
✍ Ravi D. Rao; John C. Michalak; Jeff A. Sloan; Charles L. Loprinzi; Gamini S. Soo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

## Abstract ## BACKGROUND. The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data, a multicenter, double‐blind, placebo‐controlled, crossover, randomized trial was conducted to evaluate the effec

A phase 3 randomized controlled trial of
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro